title: Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.
abstract: Toxoplasma gondii is a ubiquitous protozoan parasite that can infect all warm-blooded animals, including both mammals and birds. Protein disulfide isomerase (PDI) localises to the surface of T. gondii tachyzoites and modulates the interactions between parasite and host cells. In this study, the protective efficacy of recombinant T. gondii PDI (rTgPDI) as a vaccine candidate against T. gondii infection in BALB/c mice was evaluated. rTgPDI was expressed and purified from Escherichia coli. Five groups of animals (10 animals/group) were immunised with 10, 20, 30, 40 μg of rTgPDI per mouse or with PBS as a control group. All immunisations were performed via the nasal route at 1, 14 and 21 days. Two weeks after the last immunisation, the immune responses were evaluated by lymphoproliferative assays and by cytokine and antibody measurements. The immunised mice were challenged with tachyzoites of the virulent T. gondii RH strain on the 14th day after the last immunisation. Following the challenge, the tachyzoite loads in tissues were assessed, and animal survival time was recorded. Our results showed that the group immunised with 30 μg rTgPDI showed significantly higher levels of specific antibodies against the recombinant protein, a strong lymphoproliferative response and significantly higher levels of IgG2a, IFN-gamma (IFN-γ), IL-2 and IL-4 production compared with other doses and control groups. While no changes in IL-10 levels were detected. After being challenged with T. gondii tachyzoites, the numbers of tachyzoites in brain and liver tissues from the rTgPDI group were significantly reduced compared with those of the control group, and the survival time of the mice in the rTgPDI group was longer than that of mice in the control group. Our results showed that immunisation with rTgPDI elicited a protective immune reaction and suggested that rTgPDI might represent a promising vaccine candidate for combating toxoplasmosis.
authors: Research Institute of Medical Parasitology, Shanxi Medical University, Taiyuan, Shanxi, PR China. guorongyin@163.com
authors: Hai-Long
authors: HL
authors: Wang
authors: Ya-Qing
authors: YQ
authors: Li
authors: Li-Tian
authors: LT
authors: Yin
authors: Xiao-Li
authors: XL
authors: Meng
authors: Min
authors: M
authors: Guo
authors: Jian-Hong
authors: JH
authors: Zhang
authors: Hong-Li
authors: HL
authors: Liu
authors: Juan-Juan
authors: JJ
authors: Liu
authors: Guo-Rong
authors: GR
authors: Yin
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D017124:Conserved Sequence; D005260:Female; D015870:Gene Expression; D056724:Immunity, Humoral; D008213:Lymphocyte Activation / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D019704:Protein Disulfide-Isomerases / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D015800:Protozoan Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D016052:Protozoan Vaccines / Q000276:immunology*; D011994:Recombinant Proteins; D016415:Sequence Alignment; D014122:Toxoplasma / Q000235:genetics / Q000276:immunology*; D014124:Toxoplasmosis, Animal / Q000401:mortality / Q000517:prevention & control
chemical_list: D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; D011994:Recombinant Proteins; D019704:Protein Disulfide-Isomerases
references: Int J Parasitol. 2000 Nov;30(12-13):1217-58
references: 11113252
references: Parasite Immunol. 2007 Sep;29(9):445-53
references: 17727568
references: Free Radic Biol Med. 2012 May 1;52(9):1954-69
references: 22401853
references: Science. 2003 Jan 17;299(5605):414-6
references: 12532022
references: Parasite. 2008 Sep;15(3):389-95
references: 18814712
references: Biochim Biophys Acta. 2004 Jun 1;1699(1-2):35-44
references: 15158710
references: Parasitol Res. 2007 Jul;101(2):331-8
references: 17265053
references: Exp Parasitol. 2012 Dec;132(4):458-64
references: 23026454
references: Clin Infect Dis. 2012 Sep;55(6):845-51
references: 22618566
references: Expert Rev Vaccines. 2009 Jun;8(6):791-808
references: 19485758
references: Vaccine. 2004 Sep 28;22(29-30):4054-61
references: 15364456
references: Res Vet Sci. 2010 Aug;89(1):93-7
references: 20132954
references: Exp Parasitol. 2012 Mar;130(3):218-22
references: 22248986
references: J Biol Chem. 2003 Jan 17;278(3):1872-8
references: 12427741
references: Science. 2001 Oct 5;294(5540):161-5
references: 11588262
references: Adv Parasitol. 1992;31:1-81
references: 1496926
references: Vaccine. 2011 Mar 24;29(15):2742-8
references: 21315696
references: PLoS Pathog. 2011 Feb 10;7(2):e1001279
references: 21347348
references: Proteomics. 2003 Dec;3(12):2339-50
references: 14673785
references: Int J Mol Med. 1999 Nov;4(5):549-55
references: 10534580
references: J Cell Physiol. 2002 Nov;193(2):154-63
references: 12384992
references: Vaccine. 2008 Feb 20;26(8):1025-31
references: 18221825
references: Parasitology. 1995;110 Suppl:S11-6
references: 7784124
references: Exp Parasitol. 2008 Jul;119(3):373-8
references: 18457835
references: Microbes Infect. 2006 Apr;8(5):1244-51
references: 16616574
references: Trends Cell Biol. 2000 May;10(5):203-10
references: 10754564
references: Immunol Rev. 2011 Mar;240(1):269-85
references: 21349099
references: Vaccine. 2010 Mar 16;28(13):2556-64
references: 20117266
references: Vaccine. 2011 Jan 17;29(4):821-30
references: 21087690
references: FEBS Lett. 2002 Jul 3;522(1-3):104-8
references: 12095627
references: Vet Parasitol. 2009 Oct 14;164(2-4):134-40
references: 19592172
references: J Biol Chem. 2004 Nov 26;279(48):49780-6
references: 15377672
references: Immunol Res. 2004;29(1-3):187-96
references: 15181281
references: J Parasitol. 2001 Dec;87(6):1491-3
references: 11780848
references: J Infect Dis. 1995 Dec;172(6):1561-6
references: 7594717
references: Vaccine. 2011 Sep 2;29(38):6614-9
references: 21762755
references: Int Immunol. 2002 Nov;14(11):1291-301
references: 12407020
references: Ciba Found Symp. 1997;204:148-54; discussion 154-8
references: 9107418
references: Exp Parasitol. 2011 Aug;128(4):448-53
references: 21554876
references: Gene. 1996 Nov 28;181(1-2):221-3
references: 8973335
references: Expert Opin Ther Pat. 2012 Mar;22(3):311-33
references: 22404108
references: FEBS Lett. 2000 Nov 10;484(3):246-52
references: 11078887
references: Annu Rev Microbiol. 2008;62:329-51
references: 18544039
references: Infect Immun. 2002 Jul;70(7):3576-85
references: 12065498
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):305-14
references: 15652819
references: Eur Rev Med Pharmacol Sci. 2011 Feb;15(2):193-8
references: 21434486
references: Int J Parasitol. 2005 Nov;35(13):1459-72
references: 16129440
references: Int J Parasitol. 2002 Jan;32(1):39-51
references: 11796121
references: Vaccine. 2007 May 22;25(21):4301-11
references: 17418457
references: Exp Parasitol. 2009 Sep;123(1):81-9
references: 19508869
references: Exp Parasitol. 2009 May;122(1):41-6
references: 19545523
references: Nat Rev Immunol. 2005 Feb;5(2):162-70
references: 15662369
references: Clin Vaccine Immunol. 2006 Nov;13(11):1267-77
references: 16988008
references: Infect Immun. 1995 Jul;63(7):2549-55
references: 7790068
references: Lancet. 2004 Jun 12;363(9425):1965-76
references: 15194258